Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic and Hepatobiliary Disorders”

463 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 463 results

Not applicableWithdrawnNCT03302481
What this trial is testing

Mitochondrial Metabolism and Hepatic Complications of Obesity

Who this might be right for
Obesity
Nantes University Hospital
Large-scale testing (Phase 3)Study completedNCT00006164
What this trial is testing

Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment

Who this might be right for
Chronic Hepatitis cCirrhosis, LiverFibrosis, Liver+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1,050
Not applicableLooking for participantsNCT06863012
What this trial is testing

EUS-guided Portal Pressure Gradient (PPG) Measurement: a Potential Alternative to the Traditional HVPG

Who this might be right for
Portal HypertensionChronic Liver Disease (CLD)Cirrhosis
Fundacio Privada Mon Clinic Barcelona 20
Testing effectiveness (Phase 2)Study completedNCT00249652
What this trial is testing

Transplant and Addiction Project (TAP) - 1

Who this might be right for
End Stage Liver DiseaseEnd Stage Renal DiseaseSubstance-Related Disorders
St. Luke's-Roosevelt Hospital Center 41
Not applicableEnded earlyNCT04940416
What this trial is testing

Eye Movement Testing for Diagnosing Encephalopathy in Patients With Liver Disease

Who this might be right for
CirrhosisHepatic Encephalopathy
Stanford University 48
Post-approval studies (Phase 4)Looking for participantsNCT05305287
What this trial is testing

Quantifying Hepatic Mitochondrial Fluxes in Humans

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseType 2 DiabetesMitochondrial Metabolism Disorders
The University of Texas Health Science Center at San Antonio 60
Not applicableNot Yet RecruitingNCT03946852
What this trial is testing

Abdominal Regional Perfusion in Donation After Cardiac Death for Multi-Organ Transplantation

Who this might be right for
Liver Transplant; ComplicationsIschemia Reperfusion InjuryCirrhosis+3 more
London Health Sciences Centre 20
Post-approval studies (Phase 4)Looking for participantsNCT07521332
What this trial is testing

Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis

Who this might be right for
CirrhosisEsophageal and Gastric VaricesAscites+3 more
Asian Institute Of Medical Sciences 220
Not applicableStudy completedNCT01933789
What this trial is testing

Improving Communication About Serious Illness

Who this might be right for
Critical IllnessChronic DiseaseTerminal Care+9 more
University of Washington 817
Not applicableStudy completedNCT01874249
What this trial is testing

Non Invasive Assessment of Liver Fibrosis in Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty Liver Disease
Fundación Clínica Médica Sur 1,200
Large-scale testing (Phase 3)Study completedNCT01008293
What this trial is testing

Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of Life

Who this might be right for
Chronic Liver DiseaseHepatic Encephalopathy
CD Pharma India Pvt. Ltd. 120
Not applicableStudy completedNCT03191851
What this trial is testing

Evaluation of 'Melody' Paracentesis Device for Ascites Therapy

Who this might be right for
Ascites HepaticCirrhosis and Chronic Liver Disease
University of Nottingham 101
Large-scale testing (Phase 3)Study completedNCT02030977
What this trial is testing

The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Fatty Liver
Dr Azita Hekmatdoost 50
Not applicableActive Not RecruitingNCT06315361
What this trial is testing

DIAbetes and NAFLD

Who this might be right for
NAFLDDiabetesNASH+3 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 600
Early research (Phase 1)Study completedNCT00781430
What this trial is testing

Study Evaluating The PK And Safety Of Neratinib In Healthy Subjects And Subjects With Chronic Liver Disease

Who this might be right for
Hepatic Insufficiency
Puma Biotechnology, Inc. 27
Testing effectiveness (Phase 2)Study completedNCT00990639
What this trial is testing

Effect of Candesartan in Alcoholic Liver Fibrosis

Who this might be right for
Alcoholic Liver Disease
Yonsei University 85
Not applicableUnknownNCT05220956
What this trial is testing

Impact of Time-restricted Feeding in NAFLD

Who this might be right for
Fatty Liver DiseaseFatty LiverFatty Liver, Nonalcoholic
Johannes Gutenberg University Mainz 100
Not applicableLooking for participantsNCT07270601
What this trial is testing

Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseNAFLD - Non-Alcoholic Fatty Liver Disease
ContextVision AB 110
Large-scale testing (Phase 3)Study completedNCT05253287
What this trial is testing

Growth Hormone in Decompensated Liver Cirrhosis

Who this might be right for
Liver CirrhosisFibrosisEnd Stage Liver Disease+4 more
Post Graduate Institute of Medical Education and Research, Chandigarh 96
Not applicableActive Not RecruitingNCT06380335
What this trial is testing

Study in Patients With Decompensated Liver Cirrhosis

Who this might be right for
Liver Cirrhosis
Resolution Therapeutics Limited 24
Load More Results